These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 32862390)

  • 61. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
    Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
    BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
    Zhang Z; Li Z; Liu Z; Zhang X; Yu N; Xu Z
    J Cell Biochem; 2020 Jul; 121(7):3606-3615. PubMed ID: 31961022
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.
    Wu XR; Chen YH; Chen W; Kong W; Huang JW; Zhang J; Xue W; Liu DM; Huang YR
    Oncotarget; 2016 Jun; 7(25):38004-38009. PubMed ID: 27191742
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
    Liu Q; Zhang X; Tang H; Liu J; Fu C; Sun M; Zhao L; Wei M; Yu Z; Wang P
    Pathol Oncol Res; 2020 Jul; 26(3):1583-1594. PubMed ID: 31489573
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
    Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L
    Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
    Zhang N; Chen W; Gan Z; Abudurexiti A; Hu X; Sang W
    Medicine (Baltimore); 2020 May; 99(21):e20470. PubMed ID: 32481352
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
    Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
    Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
    J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
    [No Abstract]   [Full Text] [Related]  

  • 73. FN1 and cancer-associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma.
    Ashok G; Ramaiah S
    J Gene Med; 2023 Dec; 25(12):e3556. PubMed ID: 37358013
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
    Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma.
    Guo L; An T; Wan Z; Huang Z; Chong T
    BMC Urol; 2023 Mar; 23(1):43. PubMed ID: 36959648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
    Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y
    Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
    Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 80. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.